Gene News and Research

Latest Gene News and Research

ACMG issues recommendations on handling of incidental findings in clinical genome, exome sequencing

In a highly anticipated report, landmark recommendations on the handling of incidental findings in clinical genome and exome sequencing are being issued from the American College of Medical Genetics and Genomics.

22 Mar 2013

Fralin Life Science Institute researchers use TALENS to alter mosquito genome

Virginia Tech researchers successfully used a gene disruption technique to change the eye color of a mosquito - a critical step toward new genetic strategies aimed at disrupting the transmission of diseases such as dengue fever.

22 Mar 2013

Gene LY86 identified as likely contributor to obesity

Food and environment can chemically alter your gene function and scientists have identified a gene that is consistently altered in obesity.

22 Mar 2013

Cocaine can be lethal for people living with HIV

Cocaine, already a damaging drug for those with healthy immune systems, can be lethal for those living with human immunodeficiency virus. Mudit Tyagi, Ph.D., assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, has received two federally funded grants to study how dangerous this combination is in HIV patients.

22 Mar 2013

Blocked bile ducts can be effectively treated with metal stents

A multi-center analysis, led by Weill Cornell Medical College and published in the Journal of Clinical Gastroenterology, shows the use of temporary "fully covered self-expanding metal stents" (FCSEMS) can effectively fix a painful and potentially life-threatening benign biliary stricture -- a severely blocked or narrowed bile duct.

21 Mar 2013

WUSTL's Wang receives NSF grant to study oxygen consumption rates of individual cells

When scientists study cells, they need to know how much oxygen each cell consumes to determine its metabolism. However, existing technology limits this study to groups of cells, not individual cells. Lihong Wang, PhD, plans to change that.

21 Mar 2013

DART Therapeutics develops new class of therapy for Duchenne muscular dystrophy

DART Therapeutics Inc., an innovative, new-model biotechnology firm focused on developing therapies for Duchenne muscular dystrophy, announced today that it is developing a SARM drug candidate obtained from Belgium-based Galapagos NV.

21 Mar 2013

APS to present scientific abstracts at Experimental Biology 2013

The American Physiological Society is one of six scientific societies sponsoring the meeting Experimental Biology 2013, being held April 20-24, 2013 at the Boston Convention and Exhibition Center, in Boston, Mass.

21 Mar 2013

Cedars-Sinai surgeons perform more adult heart transplants in 2012, statistics show

For the third year in a row, the Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed more adult heart transplants than any other U.S. medical center, according to statistics compiled by the United Network for Organ Sharing, the nonprofit organization that manages the nation's transplant system.

21 Mar 2013

Online database is speeding the search for diseases caused by rogue gene

A new online database combining symptoms, family history and genetic sequencing information is speeding the search for diseases caused by a single rogue gene.

20 Mar 2013

Study explores new mechanism that may contribute to development of cancers

A study published today in the journal Nature Genetics explores a new mechanism that may contribute to the development of several tumours, including Chronic Lymphocytic Leukaemia, a type of cancer that affects more than a thousand new patients in Spain each year.

20 Mar 2013

Study provides new insights about polycystic ovarian syndrome, insulin resistance

A group of tiny RNA molecules with a big role in regulating gene expression also appear to have a role in causing insulin resistance in woman with polycystic ovary syndrome and, perhaps, in all women, researchers report.

20 Mar 2013

Study links inherited variations in few genes to increased risk of pediatric leukemia

Humans have between 20,000 and 25,000 genes that carry instructions for assembling the proteins that do the work of cells. Work led by St. Jude Children's Research Hospital found that children who inherit certain variations in four particular genes are at much higher risk of developing acute lymphoblastic leukemia.

20 Mar 2013

Research findings could lead to development of new drugs for gout treatment

Findings from a Loyola University Chicago Stritch School of Medicine study could lead to the development of new drugs to treat gout.

20 Mar 2013

Scientists to engineer anti-allergy genetically modified apples

Scientists are trying to engineer apples so that the most widely consumed fruit in Europe no longer triggers allergic reactions.

20 Mar 2013

Weill Cornell Medical College researchers call for clearer definition of population health

Accountable Care Organizations, a key feature of the Affordable Care Act, aim to control health care costs, enhance quality in health care and improve population health. But what does "improving population health" really mean? This is the question asked in a new viewpoint article by Weill Cornell Medical College researchers published in the March 20 issue of the Journal of the American Medical Association.

20 Mar 2013

New research project on systems biology of synapse proteins and ageing launched

The AgedBrainSYSBIO project on systems biology of synapse proteins & ageing was officially launched March18th in Paris, France.

20 Mar 2013

Genetic testing services for rare neurological disorders launched by Athena Diagnostics

Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available through Athena Diagnostics, a business of Quest Diagnostics (NYSE:DGX), the world’s leading provider of diagnostic information services.

From Quest Diagnostics 19 Mar 2013

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).

19 Mar 2013

A Map of 'Shortcuts' simplifies the hunt for disease-causing genes

Some diseases are caused by single gene mutations. Current techniques for identifying the disease-causing gene in a patient produce hundreds of potential gene candidates, making it difficult for scientists to pinpoint the single causative gene.

19 Mar 2013

Gene News and Research

Latest Gene News and Research

ACMG issues recommendations on handling of incidental findings in clinical genome, exome sequencing

Fralin Life Science Institute researchers use TALENS to alter mosquito genome

Gene LY86 identified as likely contributor to obesity

Cocaine can be lethal for people living with HIV

Blocked bile ducts can be effectively treated with metal stents

WUSTL's Wang receives NSF grant to study oxygen consumption rates of individual cells

DART Therapeutics develops new class of therapy for Duchenne muscular dystrophy

APS to present scientific abstracts at Experimental Biology 2013

Cedars-Sinai surgeons perform more adult heart transplants in 2012, statistics show

Online database is speeding the search for diseases caused by rogue gene

Study explores new mechanism that may contribute to development of cancers

Study provides new insights about polycystic ovarian syndrome, insulin resistance

Study links inherited variations in few genes to increased risk of pediatric leukemia

Research findings could lead to development of new drugs for gout treatment

Scientists to engineer anti-allergy genetically modified apples

Weill Cornell Medical College researchers call for clearer definition of population health

New research project on systems biology of synapse proteins and ageing launched

Genetic testing services for rare neurological disorders launched by Athena Diagnostics

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

A Map of 'Shortcuts' simplifies the hunt for disease-causing genes

eBook: Using iPSCs models for human disease research and drug discovery eBook

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices